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Abstract
Background: Bardet-Biedl Syndrome (BBS) and Alström Syndrome are two pleiotropic ciliopathies with significant
phenotypic overlap between them across many tissues. Although BBS and Alström genes are necessary for the
proper function of primary cilia, their role in defects across multiple organ systems is unclear.
Methods: To provide insight into the pathways underlying BBS and Alström phenotypes, we carried out whole
organism transcriptome analysis by RNA sequencing in established zebrafish models of the syndromes.
Results: We analyzed all genes that were significantly differentially expressed and found enrichment of phenotypically
significant pathways in both models. These included multiple pathways shared between the two disease models as
well as those unique to each model. Notably, we identified significant downregulation of genes in pathways relevant
to visual system deficits and obesity in both disorders, consistent with those shared phenotypes. In contrast, neuronal
pathways were significantly downregulated only in the BBS model but not in the Alström model. Our observations also
suggested an important role for G-protein couple receptor and calcium signaling defects in both models.
Discussion: Pathway network analyses of both models indicate that visual system defects may be driven by genetic
mechanisms independent of other phenotypes whereas the majority of other phenotypes are a result of genetic
players that contribute to multiple pathways simultaneously. Additionally, examination of genes differentially expressed
in opposing directions between the two models suggest a deficit in pancreatic function in the Alström model, that is
not present in the BBS model.
Conclusions: These findings provide important novel insight into shared and divergent phenotypes between two
similar but distinct genetic syndromes.
Background
Many Mendelian disorders are pleiotropic, characterized by
dysfunction across multiple organ systems. Deciphering the
underlying molecular etiology of such diseases can be
difficult due to the complexity of interpreting the role of a
single gene in multiple disparate cell types. This complexity
remains even for syndromes in which the subcellular defect
is relatively well understood. For example, the ciliopathies
are caused by mutations in genes encoding proteins associ-
ated with primary cilia or associated structures. However,
the molecular pathways disrupted by loss of function in
various ciliopathy genes remain relatively unclear. Two
ciliopathies in particular, Bardet-Biedl Syndrome (BBS) and
Alström Syndrome represent pleiotropic syndromes with
overlapping features, but for which the primary molecular
defects underlying those features are not well understood.
Alström Syndrome is a rare autosomal recessive,
monogenic disorder caused by mutations in the ALMS1
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gene. The ALMS1 gene is located on chromosome 2p13
and consists of 23 exons, which encode for a 461-kDa
protein [1, 2]. Over 100 different disease-causing muta-
tions have been identified in the ALMS1 gene, the
majority of which are nonsense and frameshift mutations
occurring in exons 8, 10, or 16 [1, 2]. The reported
prevalence of Alström is less than one per million in the
general population, with less than one thousand docu-
mented cases. Bardet-Biedl Syndrome (BBS) is also a
rare autosomal recessive disorder, but exhibits significant
genetic heterogeneity with 20 associated genes identified
to date [3] The most common gene mutated in BBS is
BBS1, located on chromosome 11q13, which accounts
for approximately 25 % of BBS cases [4]. The prevalence
of BBS is 1 in 160,000 in the general population, but as
high as 1 in 13,500 in a few isolated communities [4].
Both Alström and BBS are classified as ciliopathies due
to the localization of their proteins to the basal body of the
primary cilia and the subsequent ciliary dysfunction that
occurs when these proteins are disrupted. ALMS1 may be
involved in intracellular trafficking and protein transport
from the Golgi to the primary cilium [2]. Several of the BBS
proteins, including BBS1, form a protein complex called
the BBSome, which is involved in the transport of mole-
cules to the cilium and along the ciliary shaft [5, 6].
Given the potential similarities in intracellular localization
and function, it is not surprising that many of the hall-
mark clinical features of Alström and BBS are shared
between them. Both are uniquely characterized among
the ciliopathies by highly penetrant early-onset obesity
[2]. They are also both characterized by progressive
neurosensory deficits beginning in the first years of life
that typically results in hearing loss in adolescence and
blindness by adulthood [1, 2, 4, 7]. They exhibit similar
endocrine and reproductive defects, such as hypogona-
dotropic hypogonadism as well as resulting infertility.
Renal disease and respiratory illnesses are also features
commonly found in both disorders [1, 4]. Despite these
similarities, a number of differences between the disor-
ders are present, particularly in the rates of type 2
diabetes mellitus (T2DM), developmental defects, and
cognitive deficits. Alström is characterized by highly
penetrant early onset T2DM with 70 % prevalence by
the age of 20, while in BBS the prevalence is as low as
2–6 %[2]. Developmental delays are common in BBS.
They can also be present in Alström but with much
lower penetrance, and are generally global, although it
can be specific to certain areas of development. BBS is
characterized by polydactyly, which can affect all four
limbs or only the upper or lower limbs [4], but polydac-
tyly is not present in Alström. Cognitive deficits present
in BBS can vary from mild to severe with many patients
requiring special schooling. Development of autism
spectrum disorder and psychosis is also present [4]. In
contrast, the majority of Alström patients exhibit nor-
mal levels of intelligence although mild developmental
delay of fine motor skills has been observed, likely as a
result of sensory deficits [1].
Due to the high degree of phenotypic overlap between
these disorders, they are often mistaken for one another,
resulting in misdiagnosis. Here, we set out to characterize
the global molecular profiles of each disorder in an effort
to determine the underlying etiology distinguishing each
and to identify common pathways that may be shared be-
tween both. We generated zebrafish models of both disor-
ders by targeted knockdown approaches as previously
described [8, 9]. Using whole transcriptome analysis by
sequencing of RNA isolated from whole zebrafish larvae,
we examined gene expression changes in each model and
identified pathways altered as a result. Our findings re-
vealed gene expression signatures that offer insight into
the mechanisms driving unique and common features
across the disorders. These include potentially common
mechanisms underlying obesity and retinal degeneration,
hallmarks of both disorders, and suggest genetic mecha-
nisms for susceptibility to cognitive delay in BBS but not
Alström. Taken together, these findings shed light onto
the molecular etiology of two distinct but similar ciliopa-
thies, providing important insight into the extent of simi-
larity as well as important differences between them.
Results
Identification of differentially expressed genes
To identify differentially expressed genes in Alström
Syndrome (Alms) and Bardet-Biedl Syndrome (BBS),
we generated zebrafish models of either syndrome
using splice blocking morpholinos (MOs) targeting
either alms1 or bbs1 transcripts that were previously
validated to suppress protein production without intro-
duction of off-target effects [9]. MOs were injected into
wild-type zebrafish embryos. At 48 h post fertilization
(hpf ) two replicates of RNA, from pools of 20 embryos
per treatment as well as control embryos injected with
control MO were collected for whole transcriptome se-
quencing. To fully capture all organ systems that may
be impacted by disruption of either bbs1 or alms1, we
isolated total RNA from whole zebrafish at 48 hpf, a
time point at which most organ systems have developed
and begin to be functional. MO-driven knockdown at
48 hpf was verified by western blot (Additional file 1:
Figure S1.) RNA from each sample was sequenced to a
depth of ~110 million reads with 91–100 million reads
aligned to the zebrafish genome. Of these, between 85
and 88 % were mapped to exonic regions.
A total of 791 genes were significantly differentially
expressed in the alms1 knockdown compared to control.
This included 265 that were upregulated and 526 that
were downregulated (Fig. 1). Suppression of bbs1 resulted
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in a substantially larger set of genes with differential ex-
pression levels. A total of 3780 genes were found to have
significant changes in expression, with 1467 genes upregu-
lated and 2313 genes downregulated (Fig. 1). To examine
the extent of similarities between the two syndrome
models, we analyzed the sets of differentially expressed
genes and identified overlap between them. 524 genes
were differentially expressed in both alms1 and bbs1-de-
pleted larvae, 157 that were upregulated in both and 358
that were downregulated in both (Fig. 1). Interestingly,
only 8 genes exhibited changes in gene expression in op-
posing directions between the two disorders (Fig. 1). We
also examined the dataset to identify gene expression
changes that were unique to each model. 267 genes were
differentially expressed only with loss of alms1; 106 were
upregulated and 161 downregulated. Loss of bbs1 resulted
in 3256 genes whose gene expression was uniquely chan-
ged, 1302 that were upregulated and 1954 that were
downregulated. For each model, more genes were found
to be downregulated than upregulated, suggesting the
widespread negative impact of suppression of each gene.
Additionally, almost 5 times more genes were differen-
tially expressed in bbs1 compared to alms1, perhaps indi-
cating dysfunction across a greater number of cell types or
pathways in BBS.
Gene expression changes in BBS model suggest
deficiencies in neuronal and visual pathways
Given the large number of differentially expressed genes
in each model, we set out to categorize genes to assess
their potential relevance to disease phenotypes. To do so
and to more clearly elucidate the molecular profile of
our BBS zebrafish model, we sought to identify the path-
ways and gene ontologies enriched in the differentially
expressed genes. We queried the ConsensusPathDB to
identify enriched pathways in the dataset [10]. Pathways
with at least 2 differentially expressed genes were pulled
from the Reactome and Kegg databases and a cutoff q-
value of <0.05 was used. Enriched gene ontology (GO)
terms in the dataset were identified using the enrich-
ment analysis tool of the Gene Ontology Consortium
[11]. Biological process GO terms and the Danio rerio
database were used as parameters with a cutoff p-value
of <0.05. The 30 most highly changed, by number of
genes or fold enrichment, in each case are shown in
Fig. 2.
In total, 92 pathways were downregulated in the BBS
model. Aside from the very broad grouping of “disease”,
the most highly enriched pathway was the neuronal
system, with 61 genes downregulated, accounting for
22.3 % of the genes involved in this pathway (Fig. 2a).
This included genes such as grik1 (−3.74 log fold change,
LFC), kcnv1 (−3.53 LFC), kcnk3 (−3.42 LFC), and slc17a7
(−3.35 LFC), all of which were significantly downregulated
(Additional file 2: Table S1 and Additional file 3: Table
S2). Other highly enriched neuronal pathways included
transmission across chemical synapses, which contained
37 downregulated genes, neuroactive ligand-receptor
interaction with 32 genes, and axon guidance with 24
genes (Fig. 2a). This also included specific neuronal func-
tional pathways such as Glutamatergic and GABAergic
pathways, containing 28 and 21 genes, respectively. In
addition, an important neuronal pathway that was
highly enriched among the downregulated pathways
was defective ACTH and pro-opiomelanocortinin defi-
ciency (POMCD), with 31 downregulated genes (Fig. 2a).
Pro-opiomelanocortinin (POMC) is directly related to
regulation of satiety and hyperphagia and is known to be
disrupted in BBS [12–14]. It is processed through several
enzymatic steps to produce melanocyte-stimulating hor-
mone (MSH) and corticotrophin (ACTH) both of which
are implicated in other forms of obesity such as melano-
cortin receptor mutations and Cushing’s [15, 16]. In all,
pathways related to neuronal function accounted for ap-
proximately one-third of the downregulated pathways.
Perhaps unsurprisingly, some of the most highly
enriched pathways were the visual pathways, consistent
with the centrality of retinal degeneration to the BBS
phenotype. These pathways included visual transduc-
tion and visual phototransduction, both with 19 genes
downregulated. These included genes required for photo-
receptor response, such as rhodopsin, rho (−4.67 LFC)
and rhol (−3.17 LFC), guca1b (−4.18 LFC), rbp1 (−3.84
LFC) and several opsins, opn1mw2 (−3.74 LFC),
opn1lw2 (−3.36 LFC), opn1sw2 (−2.98 LFC), and
opn1sw1 (−2.83 LFC).
Several other pathways with general intracellular and
signaling roles were also significantly downregulated in
the BBS model. For example, the G protein coupled recep-











Fig. 1 Differentially expressed genes in BBS and Alström models.
Numbers of genes upregulated (red) or downregulated (yellow) in
alms1 MO (green) injected embryos, bbs1 MO (orange) injected
embryos or both compared to standard control MO injected
embryos. * Denotes number of genes changed in both but
having opposite changes in expression
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with 31 genes downregulated as well as G alpha (i) signal-
ing events with 22 genes, or 10 % of the genes involved in
the pathway. This may be consistent with the important
link between ciliary localization of GPCRs and the role of
BBS proteins in ciliary trafficking or trafficking of GPCRs
specifically [17] Calcium signaling was also enriched
among the downregulated pathways. 11.4 % (19) of the
genes involved in the calcium-signaling pathway were
downregulated. The presence of several neuronal and vis-
ual pathways is consistent with observed phenotypes of
the syndrome. BBS patients are characterized by retinal
degeneration and cognitive impairment [2, 18], potentially
as a result of disruption of neuronal signaling pathways
[17]. In addition, two pathways directly related to energy
homeostasis were among the most enriched pathways in
downregulated genes. These were related to insulin secre-
tion and integration of energy metabolism. The former
may be directly related to glucose homeostasis and evi-
dence suggests that it may be directly perturbed in BBS
[19, 20], but both pathways are likely relevant to overall
defects in energy metabolism, consistent with the obesity
phenotype that is a hallmark of BBS.
169 GO terms were enriched among the downregulated
genes (Fig. 2b). The top downregulated GO terms were
highly consistent with the top downregulated pathways.
The most highly enriched GO terms included several
related to the neuronal and visual systems such as: regula-
tion of neuronal synaptic plasticity and regulation of
synapse structure or activity, and phototransduction, de-
tection of light stimulus, and visual perception. Several
GPCR GO terms were also found, including termination
of GPCR signaling pathway and negative regulation of
GPCR protein signaling (Fig. 2b).
Although the number of genes upregulated in the BBS
model was considerably lower than the number downreg-
ulated, these genes encompassed a much greater number
of pathways. This is likely due to the smaller number of
differentially expressed genes found in each upregulated
pathway. In total, 170 pathways were upregulated in the
BBS model. The majority of the upregulated pathways are
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those involved with the cell cycle, including mitosis and
the S phase, and those involved with transcription, in-
cluding several RNA polymerases (Fig. 2c). 159 GO
terms were enriched among the upregulated genes and
were consistent with the upregulated pathways (Fig. 2d).
The majority were involved in RNA processing such as:
exonucleolytic trimming involved in rRNA processing,
maturation of 5.8S rRNA, tRNA methylation, rRNA pro-
cessing, and ribosome biogenesis. These observations sug-
gest a previously underappreciated role for BBS genes in
regulation of cell cycle events, transcription and transla-
tion. Interestingly, the most highly enriched GO term
among the upregulated genes is cilium-dependent cell
motility consistent with the known roles of BBS genes in
ciliogenesis and cilia function [5, 13].
Analysis of pathways disrupted in Alström model
suggests importance of phototransduction signaling
We next characterized the gene expression signature,
pathways and gene ontologies enriched in larvae targeted
for alms1 expression. The Alström model exhibited fewer
enriched pathways, with less genes contained, as well as
fewer enriched GO terms, compared to the BBS model.
Only 23 pathways were represented in the set of downreg-
ulated genes (Fig. 3a) and 47 GO terms (Fig. 3b). There
were no significantly upregulated pathways or enriched
GO terms in the Alström model.
Similar to the BBS model, many of the downregulated
pathways involved the visual pathways including, diseases
associated with visual transduction and visual phototrans-
duction. Other enriched visual pathways include: inactiva-
tion, recovery and regulation of the phototransduction
cascade and the phototransduction cascade, each with 7
downregulated genes, as well as, activation of the photo-
transduction cascade with 5 of the 12 involved genes
(45 %) being downregulated. This is consistent with the
retinal degeneration phenotype that is likewise character-
istic of Alström [1, 2, 21]. Furthermore, the POMC path-
way was also downregulated in alms1 as it was in bbs1,
consistent with hyperphagia induced obesity observed in
the disorder [1]. Pathways involved with GPCR and
calcium signaling were found to be downregulated in
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Fig. 3 Top up- and downregulated pathways and enriched GO terms in Alström model. a Top downregulated pathways by number of genes.
b Top downregulated GO terms by fold enrichment. c Top upregulated pathways by number of genes
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alms1 as they were in bbs1. However, in each of the cases
mentioned, considerably fewer genes were found in the
pathways in alms1 than were found in bbs1.
47 GO terms were enriched among the downregulated
genes. Consistent with the downregulated pathways, the
most highly enriched GO terms associated with down-
regulated genes were all involved with the visual system,
including phototransduction, visual perception, and de-
tection of light stimulus (Fig. 3b). Several GPCR related
GO terms were also highly enriched, such as termination
of GPCR signaling pathway and regulation of GPCR pro-
tein signaling pathway. Although these terms reflect a
high degree of overlap between the BBS and Alström
models, the neuronal pathways that were prevalent in
bbs1-depleted larvae were noticeably absent from both
the downregulated pathways and enriched GO terms in
alms1-deficient animals. This may be consistent with ab-
sent or very mild cognitive impairment in Alström pa-
tients [1], contrasting with BBS.
Overlap of differential gene expression between BBS and
Alström models
The phenotypic overlap between BBS and Alström often
results in their being mistaken for one another. Our
whole transcriptome approach allowed us to compare
the two models at the molecular level to assess areas of
molecular overlap that might underlie similar pheno-
types and areas of divergence that might inform the
uniqueness of each disorder. We first examined the ex-
tent of overlap between the two. Animals with reduced
alms1 had a much larger proportion of differentially
expressed genes in common with the BBS model (66 %)
than genes unique to itself (34 %) (Fig. 4a). In contrast,
the BBS model exhibited a more unique spectrum with
86 % of the differentially expressed genes unique to it
and only 14 % in common with the Alström model. This
suggests that nearly all of the Alström phenotypes may
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Fig. 4 Overlap of differential expression between BBS and Alström models. a Percentage and number of differentially expressed genes found
unique to each disease model (red) and shared across both models (blue). b Downregulated pathways by number of genes downregulated in
both models. c Downregulated GO terms by fold enrichment of genes downregulated in both models. Number of genes or GO terms downregulated
in the BBS model (green), in the Alström model (red) or both (blue) indicated
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We then looked at the pathways and GO terms down-
regulated in both models to assess overlap. 24 pathways
were downregulated in both models (Fig. 4b). In almost
every case, the number of genes downregulated in the
shared pathways was greater in the BBS model. The ma-
jority of genes differentially expressed in alms1-deficient
animals were also differentially expressed in animals
targeted for bbs1. Pathways associated with the visual
system were the most commonly downregulated path-
ways in both models. The POMC pathway was also one
of the top downregulated pathways found in both. Other
pathways that were downregulated in both disorders
include those associated with GPCRs and the calcium-
signaling pathway.
47 GO terms were enriched among the downregulated
genes found in both models. The 30 terms with the
greatest enrichment in the downregulated genes found
in both are shown in Fig. 4c. The enriched GO terms
were consistent with the pathways, again, with the most
highly enriched GO terms associated with the visual sys-
tem including: phototransduction, detection of light
stimulus, visual perception, and sensory perception of
light stimulus. Several GPCR terms were also found to
be downregulated in both, such as termination of GPCR
signaling pathway, negative regulation of GPCR protein
signaling, and GPCR signaling pathway.
To assess the extent to which downregulated path-
ways may be interconnected we generated pathway
networks. For the BBS model, the pathway network re-
vealed two distinct, unconnected, nodes (Fig. 5a). One
node encompassed the interconnected visual pathways,
while the other incorporated the remainder of the path-
ways. This larger node reveals the connectivity among
the neuronal pathways as well as a high degree of connect-
ivity to the other affected pathways, such as calcium sig-
naling, insulin secretion, and energy metabolism. Given
the significantly smaller number of genes and pathways,
the Alström model resulted in a simpler, less connected,
network (Fig. 5b). In this network we again found that all
of the pathways associated with the visual system clus-
tered together with a high degree of interconnectivity be-
tween them. However, the visual pathways node was also
connected to both the Ca2+ pathway and signal transduc-
tion. There were also several pathways that showed no
overlap with any other pathway including, extracellular
matrix organization, potassium channels, and primary
immunodeficiency. Finally, to examine the relatedness be-
tween the disease models we generated a pathway network
Fig. 5 Pathway networks of overlapping genes in BBS and Alström models. Pathway analysis of top 30 downregulated pathways among differentially
expressed genes in BBS model (a) or in Alström model (b). c Pathway connectivity of downregulated pathways found in both models. Pathway
connections determined by a minimum of 20 % shared genes between pathways and at least 2 genes overlap
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for the genes that were downregulated in both models
(Fig. 5c). Similar to the Alström model, the visual path-
ways formed a highly interconnected node, connecting
only to the Ca2+ pathway and signal transduction. This
suggests that overlap between visual signaling and Ca2+ or
signal transduction may indeed be relevant to both disease
models, but perhaps relies on a small subset of genes
whose contribution in the BBS model was dwarfed simply
by the large number of disrupted genes. The remainder of
the shared pathways all showed some degree of overlap
among them, with the exception of opsins, although not
to the extent that was seen in the BBS model.
Our examination of the overlap between these path-
ways allowed us to identify genes that exert a greater
impact on the spectrum of phenotypes observed in
these disorders based on their contribution to a larger
number of pathways. For example, downregulation of
the G protein genes gngt1, gng7, and gng8, as well as
the GABA receptor genes gabrb2, gabrb3, gabra1,
gabra2, gabra3, and gabrg2 in BBS may be driving the
cognitive deficits characteristic of the disorder, as these
genes were found in the majority of the downregulated
neuronal system pathways. Each of these genes contrib-
uted to greater than 20 % of the pathways identified
perhaps indicating a broad phenotypic spectrum driven
by a relatively small number of genes. Indeed, gngt1
alone contributed to nearly 60 % of pathways, indicat-
ing its potential importance in contributing to multiple
phenotypes (Additional file 4: Figure S2A). Addition-
ally, downregulation of rhodopsin rho, gnat1, grm1,
grm5, pde6b, and opn1mw2 in both Alström and BBS
may be major drivers of the retinal degeneration that is
characteristic of both disorders, as these genes were
found in the majority of the downregulated visual and
phototransduction pathways (Additional file 4: Figure
S2A-B).
Gene expression changes provide insight into unique
molecular features of BBS
The majority of the gene expression changes in the BBS
model were unique to it, while the majority of gene ex-
pression changes in the Alström model were shared with
BBS. To assess the molecular profile that distinguishes
BBS from Alström, we examined the downregulated
pathways and enriched GO terms of the genes that were
unique to BBS. 66 pathways were identified among the
downregulated genes unique to BBS. The pathways
containing the greatest number of genes are shown in
Fig. 6a. Many of the most highly downregulated path-
ways are those related to the neuronal pathways similar
to what was seen in the full set of genes downregulated
in bbs1. However, unlike what was seen in the full set,
none of the visual pathways, POMC pathway, or GPCR
pathways were found to be downregulated in the gene
set unique to bbs1 indicating that these are the primary
areas of overlap with Alström. This also suggests that
downregulation of the neuronal system may be a unique
characteristic of BBS.
117 GO terms were enriched among the unique to bbs1
downregulated genes, the GO terms with the greatest
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Fig. 6 Top downregulated pathways and enriched GO terms unique to the BBS model. a Top 30 downregulated pathways by number of genes
only differentially expressed in the BBS model. b Top 30 downregulated GO terms by fold enrichment of genes only differentially expressed in
the BBS model
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enrichment are shown in Fig. 6b. Again, most of the
top GO terms were related to the neuronal system, in-
cluding regulation of neuronal synaptic plasticity, syn-
apse assembly, and synaptic transmission, supporting
the evidence that neuronal system defects may be a
characteristic marker of BBS that is not shared with
Alström. Also absent in the unique enriched GO terms
were those related to the visual system and GPCR sig-
naling, similar to the unique downregulated pathways.
Opposite changes in expression
Our observations suggested a high degree of overlap
between these syndromes. We reasoned, however, that
gene expression changes in opposing directions might
provide insight into the molecular basis for what differ-
entiates these two distinct syndromes from each other.
In total, only 8 genes exhibited expression changes in
opposing directions. 2 of these were uncharacterized
genes, providing little insight into their function. Only
one gene, smc1b, was upregulated in the Alström
model and downregulated in BBS (Fig. 7) while the
remaining 7 genes were all downregulated in Alström
but upregulated in BBS. Interestingly, 2 of these 7 genes
have relevance to pancreatic function. These include
chymotrypsin-like elastase family, member 1, cela1, a
pancreatic enzyme that is not expressed in the pancreas
in human, and protease serine 2 (trypsin 2), prss2a,
encoding a member of the trypsin family of serine pro-
teases. Chymotrypsin-like elastase family members are
the major components of pancreatic elastase, which
cleave tropoelastin at one of two conserved hydropho-
bic domains [22, 23]. CELA1 has also been linked to
chronic pancreatitis, as patients with chronic pancrea-
titis commonly have very low levels of elastase [24].
PRSS2A is an exocrine pancreas protease, secreted by
the pancreas and cleaved to its active form in the small
intestine for the breakdown of proteins to amino acids.
Once activated, PRSS2A cleaves peptide linkages in-
volving the carboxyl group of lysine or arginine [25]. It
is noteworthy that 2 of the 8 genes that had opposite
changes in expression between the disorders are pan-
creatic enzymes, suggesting that the pancreatic en-
zymes may play a role in the differences observed
between Alström and BBS. To further investigate the
relevance of this observation, we examined all down-
regulated genes in the Alström model to assess poten-
tial effects on other pancreatic enzymes. We found 3
other pancreatic proteases that were either downregulated
in alms1, trypsin (try) and chymotrypsinogen B1 (ctrb1),
or upregulated in bbs1, chymotrypsin-like (ctrl), suggest-
ing a role for the pancreatic proteases specifically in pro-
ducing some of the differences between these 2 disorders.
To validate these observations we assessed expression of






















Gene Symbol Gene Name Control LFC BBS/Control 




smc1b Structural maintenance of chromosomes 1B 1.05561173438691 -1.0471592522483 2.15E-05 2.16E-02 1.04E-04 4.30E-02
SNORD31 Small nucleolar RNA SNORD 31 -1.13956312809506 1.08505543451245 4.40E-03 1.10E-03 1.34E-02 2.70E-03
c3b Complement component 3b -1.1441203976036 1.77360587017591 1.24E-03 3.37E-12 4.28E-03 1.80E-11
vtg7 Vitellogenin 7 -1.15653541738146 3.65875750584613 4.48E-09 1.62E-270 3.52E-08 1.28E-267
CELA1 Chymotrypsin-like elastase family, member 1 -1.20656409521594 1.16008713103827 1.33E-06 3.24E-09 7.64E-06 1.39E-08
PRSS2a Protease, serine, 2 (trypsin 2) -2.82306378906186 1.84646915453077 1.23E-10 1.89E-15 1.13E-09 1.25E-14
FP243385.1 Uncharacterized protein -1.00141529628791 1.84295017338213 1.50E-02 1.17E-10 3.96E-02 5.61E-10
CABZ01063789.1 Uncharacterized protein -1.91081104725271 1.50134799726577 8.61E-10 1.97E-13 7.27E-09 1.14E-12
a 
b 
Fig. 7 Genes differentially expressed in opposing directions between BBS and Alström models. a Log fold change (LFC) of genes differentially
expressed in opposite directions between both disease models. b Table showing gene names, LFC relative to controls, p-values relative to controls,
and false discovery rates (FDR) for 8 genes showing opposing changes in differential expression among BBS and Alström models
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control by qRT-PCR. Expression changes relative to con-
trols exhibited similar trends, with reduced expression in
the Alström model and either increased or unchanged in
the BBS model (Additional file 5: Figure S3).
Discussion and conclusions
In this study, we have undertaken a comprehensive
transcriptomic approach in models of BBS and Alström
syndrome with the goal of identifying genetic pathway
mechanisms underlying phenotypes associated with
these disorders. Our use of the zebrafish model allowed
for assessment of gene expression across the whole organ-
ism, an approach that is particularly relevant to multi-
organ syndromes. Although our assessments were limited
to the window of analysis to embryonic and early larval
stages due to the use of transient knockdown to generate
the disease models, the nature of these syndromes as de-
velopmental disorders suggests that these may be the most
relevant time points for onset of most phenotypes associ-
ated with disease. Indeed, the majority of the hallmark
features of either disorder manifest within the first or sec-
ond decade of life, consistent with developmental or early
childhood onset [1, 2, 4, 7]. Our global analysis revealed
important insights into the pathways likely contributing to
disease phenotypes. These included known mechanisms,
such as the POMC deficiency reported in BBS models to
underlie hyperphagia and obesity [13, 14], as well as per-
haps novel mechanisms, such as the neuronal pathways
identified that may relate to cognitive impairment. Taken
together, the results of these analyses offer novel candidate
genes and pathways for further exploration in the study of
these disorders and related ciliopathies.
Our observations in the BBS model shed light onto
the potential role of BBS genes as well as phenotypes
driven by their dysfunction. For example, perhaps the
most prominent feature of BBS is retinal degeneration
characterized by rod-cone dystrophy [4, 19]. Previous
reports have attributed this feature to the importance
of the photoreceptor primary cilium and trafficking
within it [26]. Our findings suggest the specific perturb-
ation of genes in the phototransduction pathway, such
as rho (−4.67 LFC), gngt1 (−2.38 LFC), and pde6g
(−1.80 LFC), or the visual transduction pathway, such
as gnat1 (−3.32 LFC), cnga1 (−3.64 LFC), and pde6b
(−1.71 LFC). It is unclear if this disruption is a cause or
consequence of other primary factors driving retinal de-
generation, but they potentially offer novel factors to
examine in models of BBS or in patients. Interestingly, our
analysis of the interconnectedness between pathways sug-
gests little overlap between the disrupted vision pathways
and neuronal signaling. The exception to this in the
BBS model was the presence of the gngt1 gene, which
contributed to both the visual and neuronal pathways.
It is unlikely, however, that downregulation of this gene
is sufficient for neuronal deficits given the absence of
neuronal system effects in the Alström model. This poten-
tially indicates the specificity of the retinal phenotype to
that structure, rather than a general consequence of neur-
onal dysfunction. BBS is characterized by deficits in both
functions and it is therefore unsurprising that pathways
important to both tissues are perturbed with loss of bbs1.
In contrast, a higher degree of connectedness was ob-
served between neuronal pathways and energy metabol-
ism regulation, including insulin secretion, potentially
implicating neuronal regulation in those defects.
Other pathways disrupted in the BBS model offer novel
insight into phenotypes associated with the disorder. For
example, a number of basic cellular functions appear to be
upregulated in the BBS model. This included cell cycle
processes as well as transcriptional and translational regu-
lation. Much evidence supports the role of ciliary proteins
in regulation of the cell cycle, given the tight light between
ciliogenesis and proliferation [27], but our observations
perhaps suggest a more direct role for the BBS genes in
regulation of transcription or translation. This may be
consistent with the recently proposed role of BBS7 as a
transcription factor [28].
Because BBS and Alström syndrome are often mistaken
for one another we set out to characterize the extent of
overlap in differential gene expression between models of
both. Surprisingly, the Alström model exhibited far fewer
genes that were differentially expressed and the majority
of these were shared with BBS. As a result of this, almost
all of the pathways and GO terms that are enriched in the
Alström model were shared with the BBS model (Fig. 8).
In particular, the disruption of vision related pathways and
the POMC pathway, as well as GPCR signaling and
calcium signaling were common to both models. The
relatively fewer disruptions observed in the Alström
model may be consistent with the smaller number of phe-
notypes and organ systems impacted by loss of alms1. For
example, Alström patients do not typically exhibit cogni-
tive impairment and this was reflected by the noticeable
absence of disrupted neuronal signaling in the Alström
model. In contrast, the differentially expressed genes in
the BBS model were highly enriched in the neuronal path-
ways, indicative of the centrality of cognitive and perhaps
other neuronal defects to the disorder. Similarly, very few
genes were upregulated in the Alström model relative to
the BBS model. However, similar cellular processes were
impacted. These observations might suggest that the
ALMS1 protein is perhaps less critical for ciliary function
or other basic functions influenced by the basal body to
which it and the BBS proteins localize [8, 13, 29–32]. In
general, the larger number of genes altered in the BBS
model and the larger number of genes contributing to
the highly enriched pathways suggests a greater degree
of dysfunction than in the Alström model. While these
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observations offer important insight into the overlap
and the discrepancies between the two, shedding light
onto unique diagnostic criteria to differentiate between
them, they also provide important common mecha-
nisms by which the shared phenotypes are mediated.
Perhaps the most intriguing observation relates to the
genes that were differentially regulated in each model but
with divergent directionality. Only 8 genes fit this criteria,
two of which were uncharacterized and therefore of un-
known relevance. Interestingly, however, two of the eight
genes were pancreatic proteases downregulated in the
Alström model and upregulated in the BBS model. We
also identified 3 other pancreatic protease genes that were
downregulated in the Alström model but unchanged in
the BBS model. Although these enzymes relate specifically
to exocrine pancreatic function, they may offer a novel
mechanism by which differences in either exocrine or
endocrine pancreatic function occur between the two dis-
orders. The prevalence of diabetes in Alström is far higher
than that in BBS and is at least in part likely due to deficits
in endocrine pancreas function [9]. Our data might sug-
gest a novel interaction between exocrine and endocrine
pancreas. Moreover, given the importance of pancreatic
enzymes in digestion, these observations might suggest a
mechanism by which digestive phenotypes, a secondary
feature of Alström [1, 7], might arise.
In summary, our analysis of zebrafish models of two
related but distinct syndromes offers novel insight into
the mechanisms underlying their phenotypes. These data
confirm previously proposed mechanisms of dysfunction
for the common phenotypes, such as obesity, while at
the same time offering new mechanisms for many fea-
tures of both syndromes. Importantly, these findings dis-
tinguish the two disorders from each other and perhaps
suggest novel disruptions of cell types and pathways in
each. Finally, these results inform the understanding of
how BBS1, ALMS1 and cilia may function at the cellular
level. These global gene expression data represent a




Experiments were carried out in wild type Tubingen
(WT) zebrafish. Adult zebrafish were housed and natur-
ally mated according to standard protocol. All zebrafish
work was conducted in accordance with University of
Maryland IACUC guidelines.
Morpholinos
Morpholino antisense oligonucleotides (MOs) that
block splicing of targeted mRNAs were injected into
one- to two- cell stage embryos. We used previously
validated MOs to target bbs1 and alms1 transcripts [9]. A
control non-specific MO was used (5′-CCTCTTACCT
CAGTTACAATTTATA-3′). The embryos were grown at
28.5 °C until 48 h post fertilization (hpf) for analyses.
RNA extraction and sequencing
Groups of 20 embryos were pooled for each condition
(control MO, alms1 MO, bbs1 MO) at 48hpf for RNA ex-
traction. RNA was extracted using Isol-RNA Lysis Reagent
(5 Prime) and purified using Qiagen RNeasy cleanup kit
according to manufacturer’s protocol. The three RNA
samples were sent in duplicates for sequencing and pri-
mary analysis. 2 ug of total RNA per sample was used.
Illumina RNAseq libraries were prepared using the
TruSeq RNA Sample Prep kit (Illumina, San Diego,
CA). Libraries were barcoded and pooled, and each re-
ceived 0.33 of a lane of sequencing on an Illumina
HiSeq 2500 with a paired-end 100 base configuration.
Library construction and sequencing was performed at
the Institute for Genome Sciences of the University of
Maryland, School of Medicine (IGS).
RNA-sequencing data analysis
Sequenced reads were aligned to the zebrafish genomes
(Zv10) using TopHat [33]. Gene expression levels (read
counts) were calculated using HTseq [34] based on
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117 GO terms 
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Fig. 8 Summary of pathway and GO term analysis results. a Pathway
analysis summary of upregulated and downregulated enriched
pathways found in the BBS model (red), the Alström model (blue) or
both. b Gene Ontology (GO) term analysis summary of upregulated
and downregulated enriched GO terms found in the BBS model (red),
the Alström model (blue) or both
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were then normalized using reads per kilobase per mil-
lion reads (RPKM). An average of 28,700 features were
detected as expressed in each sample set. Replicate ana-
lysis and differentially expressed genes were determined
using DEGseq [36]. Both alms1 and bbs1 knockdowns
were compared to the control, cutoffs of false discovery
rate (FDR) <0.05 and p value <0.05 were used to iden-
tify genes with significant changes in expression. Pri-
mary data analysis was performed at the Institute for
Genome Sciences of the University of Maryland, School
of Medicine (IGS). Sequence data for samples is pub-
licly available through the NCBI Sequence Read Arch-
ive (SRA), Submission ID “University of Maryland BBS
Alstrom Zebrafish RNA-Seq”.
qRT-PCR
RNA was extracted from pools of 20 48hpf embryos using
Isol-RNA Lysis Reagent (5 PRIME). The RNA was puri-
fied by 3 M sodium acetate and isopropanol precipitation,
and spun for 10 min at 4° (12,500 rpm) following a 20 min
incubation. The RNA pellet was then washed in 70 %
ethanol and re-suspended in RNase free water. cDNA was
transcribed using Fermentas First Strand cDNA transcrip-
tion kit (Thermo Scientific) according to manufacturer’s
protocol. cDNA was then diluted 1:3. qRT-PCR was per-
formed using target specific primers and LightCycler 480
SybrGreen (Roche) according to manufacturer’s protocol
on a LightCycler 480 machine (Roche). All samples were
run in duplicate with CT value normalized to β-actin.
Western blots
Western blotting was performed according to previously
described protocol [9].
Determination of enriched pathways
Pathways enriched among the genes exhibiting changes in
expression were determined by uploading sets of the dif-
ferentially expressed genes to ConsensusPathDB (http://
cpdb.molgen.mpg.de). Genes were identified based on
their gene symbol (HGNC symbol). Pathways from the
KEGG and Reactome databases were used, along with a q-
value cutoff of <0.05 and a minimum of 2 genes overlap
with the input list.
Generation of pathway networks
Pathway networks were generated using the Consensus-
PathDB in the same manner as the enriched pathways.
Once the enriched pathways were determined, the top 30
most highly significantly enriched pathways were selected
for visualization. Pathways were shown as connected if
there were at least 2 genes overlapping and the pathways
shared at least 20 % of their genes.
Determination of enriched gene ontologies
Gene ontologies enriched among the differentially
expressed genes were determined using the GO Enrich-
ment Analysis tool of the Gene Ontology Consortium
(http://geneontology.org/page/go-enrichment-analysis).
Gene lists were uploaded to the tool and queried against
the biological process Danio rerio gene ontology reference
database, a cutoff p-value of <0.05 was applied.
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